Mar
22-22

Antibody Drug Conjugates as a New Class of Agents in Treating Recurrent Ovarian Cancer

This event will be held daily from
6:45 PM to 8:00 PM

The GOG Partners Leadership will present an Independent Satellite Symposia during The SGO Virtual Annual Meeting on Women’s Cancer®. This session will focus on the novel therapeutic agents available and designed to target specific ovarian cancer tumor cells.

event info

The GOG Foundation, Inc. welcomes gynecologic oncologists, oncologists, advanced practitioners (NP/PA/PharmD), and other clinicians who treat patients with gynecologic malignancies to attend a complimentary symposium on Monday, March 22, 2021, 6:45 pm – 8:00 pm CT.

Click here to register.

The GOG Partners Leadership will present “Antibody Drug Conjugates as a New Class of Agents in Treating Recurrent Ovarian Cancer”, An Independent Satellite Symposia during The SGO Virtual Annual Meeting on Women’s Cancer®. This session will focus on the novel therapeutic agents available and designed to target specific ovarian cancer tumor cells. The physician leadership will review the advancements in treatment options currently available.

Expert physician leadership speaking on these important topics include:

  • Robert L. Coleman, MD, US Oncology Research, Houston, Texas, USA
  • David O’Malley, MD, The Ohio State University Medical Center, Columbus, Ohio, USA
  • Amit Oza, MD, Ontario Institute for Cancer Research, Toronto, Ontario, Canada
  • Deb Richardson, MD, University of Oklahoma, Oklahoma City, OK, USA
  • Gottfried Konecny, MD, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA

The GOG Foundation, Inc. would like to thank its commercial supporters for Independent Medical Education Support associated with this Symposium: Mersana and Immunogen.

If you have questions about this symposium, please contact info@gog.org.

Online Meeting
Website: https://www.gog.org/gog-iss-sgo-adc-2021-reg/
  • This event has passed.


Organizer
GOG Foundation

Name: GOG Foundation